The Biologics Boom: Redefining the Landscape of Global Pharmaceutical Competition The dynamics of pharmaceutical market share are increasingly dictated by the performance and pipeline depth within the biologics segment. These large-molecule drugs, which include monoclonal antibodies and advanced protein therapies, offer high efficacy in complex disease areas like oncology and immunology, leading to premium pricing and significant revenue streams for innovators. The shift...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
